<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Public Health">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Public Health</JournalTitle>
      <Issn>2251-6085</Issn>
      <Volume>49</Volume>
      <Issue>11</Issue>
      <PubDate PubStatus="epublish">
        <Year>2020</Year>
        <Month>10</Month>
        <Day>27</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">11, 13-Dehydro Lactone Moiety in Gynecologic Cancer Cells</title>
    <FirstPage>2103</FirstPage>
    <LastPage>2110</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Yibing</FirstName>
        <LastName>LIU</LastName>
        <affiliation locale="en_US">Department of Medical Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China</affiliation>
      </Author>
      <Author>
        <FirstName>Qingju</FirstName>
        <LastName>MENG</LastName>
        <affiliation locale="en_US">Department of Orthopedics, The First Hospital of Xingtai, Xingtai, Hebei Province, China</affiliation>
      </Author>
      <Author>
        <FirstName>Li</FirstName>
        <LastName>JING</LastName>
        <affiliation locale="en_US">Department of Medical Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China</affiliation>
      </Author>
      <Author>
        <FirstName>Li</FirstName>
        <LastName>FENG</LastName>
        <affiliation locale="en_US">Department of Medical Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China</affiliation>
      </Author>
      <Author>
        <FirstName>Zhiguo</FirstName>
        <LastName>ZHOU</LastName>
        <affiliation locale="en_US">Department of Medical Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China</affiliation>
      </Author>
      <Author>
        <FirstName>Zhiyu</FirstName>
        <LastName>NI</LastName>
        <affiliation locale="en_US">School of Basic Medical Science, Hebei University, The Affiliated Hospital of Hebei University, Bao ding, Hebei Province, China</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2020</Year>
        <Month>06</Month>
        <Day>28</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2020</Year>
        <Month>08</Month>
        <Day>20</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: To study the anti-cancer effect of isoalantolactone, a sesquiterpene&#xA0;&#xA0;&#xA0; lactoneisolated from the roots of Inula heleniumon human gynecologic cancer cells.
&#xD;

Methods: A structure-activity relationship experiment was designed to identify the functional moiety of isoalantolactone for its significant anti-cancer activity. Five gynecologic cancer cell lines were treated with isoalantolactone. Cell proliferation was determined by MTT assay in vitro and cell apoptosis by flow cytometry.
&#xD;

Results: We found isoalantolactone strongly inhibited the cell proliferationofHEC-1, HAC-2, HOC-21, and HeLa cells. Its inhibitory effect was comparable to that of well-known chemotherapeutic agents, cisplatin and taxol. Furthermore, isoalantolactone induced apoptosis in HeLa cells via caspase. On the contrary, its 11, 13-dihydro derivatives had much weaker anti-proliferative activities than the parent compound.
&#xD;

Conclusion: Isoalantolactone exhibited strong anti-proliferative activities and apoptosis-inducing effects on gynecologic cancer cells. The 11, 13-dehydro lactone moiety was critical for its anti-proliferative activity.</abstract>
    <web_url>https://ijph.tums.ac.ir/index.php/ijph/article/view/21280</web_url>
    <pdf_url>https://ijph.tums.ac.ir/index.php/ijph/article/download/21280/7037</pdf_url>
  </Article>
</Articles>
